MED13L mutations were originally described as a cause of a transposition of the great arteries [31] and more recently in patients with a distinct syndromic phenotype encompassing facial anomalies, conotruncal cardial defects, and ID [32], as well as in patients with a presumably recognizable dysmorphic syndrome without cardiac involvement [33]. Here, MED13L is linked to Down syndrome.